Trial intelligence / Profile preview

Intravenous ibuprofen versus intravenous ketorolac for renal colic pain

IRCT20220820055748N1Phase 3Completed

Sponsor
Ahvaz Jundishapur University of Medical Sciences
Start
Sep 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of ibuprofen and ketorolac in Renal colic (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Renal colic pain severity, Pain relief and 1 more. Started Sep 2022; status: completed.

02

Drugs

ibuprofenketorolac
03

Conditions

Renal colic

Beyond the preview

Go deeper on IRCT20220820055748N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220820055748N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call